Experienced Chief Medical Officer with a demonstrated history of working in the biotechnology industry from large companies to start-ups. Skilled in running and providing leadership to large medical departments incl Clinical Science, Medical Affairs, Clinical Operations and Biometrics. Versed in Personalized Medicine, Cancer, and Infectious Diseases with more than 175 Pubmed-listed articles. Strong professional with a M.D. obtained from Freie Universität Berlin.
Oliver Liesenfeld is an experienced Chief Medical Officer with 29.3 years of work experience in the biotechnology industry. He has worked in various roles, including Chief Medical Officer and Head of Clinical Affairs at Inflammatix, Inc. and Roche. Oliver is skilled in immunology, microbiology, clinical research, infectious diseases, and biotechnology. He has a strong background in Personalized Medicine, Cancer, and Infectious Diseases with over 175 publications. Oliver holds an M.D. from Freie Universitat Berlin. He is currently based in San Francisco, California.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation
Charité – Universitätsmedizin Berlin sees itself as a toplevel European location for medical research and patient care. Originally established in 1710 as a quarantine hospital outside the gates of Berlin, the Charité is inseparably linked with innovative scientifi c, medical and nursing achievements as well as with the names of outstanding physicians, including the pathologist Rudolf Virchow, the surgeon Ferdinand Sauerbruch and the founder of modern bacteriology, Robert Koch. The Charite‘s present-day corporate structure is the result of a comprehensive reorganization of Berlin‘s university medicine sector following the reunifi cation of Germany. This process involved several stages and was completed in 2003 with the merger of the medical faculties of the Free University and Humboldt University, together with their respective university hospitals. Following the union of all university medical facilities in the east and west of the city, the Charité is now one the largest university hospitals in Europe. Its clinics and institutes, which are organized in 17 so-called CharitéCenters, employ some 10,400 members of staff – not including inactive full-time and thirdparty funded staff. They all are committed to the mission “Research, Teaching, Healing, Helping” – in patient care and scientific investigation as well as in training the medical and nursing staff of tomorrow.
We found 2 Oliver Liesenfeld's email addresses
We found 1 Oliver Liesenfeld's phone numbers
Oliver Liesenfeld's social media include: Linkedin,
Oliver Liesenfeld works for Inflammatix, Inc.
Oliver Liesenfeld's role in Inflammatix, Inc. is Chief Medical Officer
Oliver Liesenfeld works in the industry of
Oliver Liesenfeld's colleagues are
Oliver Liesenfeld's latest job experience is Chief Medical Officer at Inflammatix, Inc.
Oliver Liesenfeld's latest education in Freie Universität Berlin